Laboratorios Richmond S.A.C.I.F. (RICH.BA)
Buenos Aires · ARS · Healthcare · Drug Manufacturers - Specialty & Generic
ARS 1,300.00 (-1.52%) as of
Key statistics
- Market cap
- 104.98B
- P/E (TTM)
- 7.40
- EPS (TTM)
- 175.64
- Dividend yield
- 2.43%
- 52-week range
- 1,300.00 – 2,215.00
- Beta
- -0.63
- Revenue (TTM)
- 114.02B
- Profit margin
- 10.97%
- Volume
- 96.00
About Laboratorios Richmond S.A.C.I.F.
Laboratorios Richmond S.A.C.I.F., together with its subsidiaries, develops, manufactures, and sells pharmaceutical products in Latin America, Africa, Asia, and the Middle East. It offers antiretroviral drugs for the treatment of human immunodeficiency virus; oncology and oncohematology drugs; cardiometabolism drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs, such as analgesics, antipsychotics, antidepressants, anti-dementia, antiepileptics, and hypnotic drugs, as well as drugs for the treatment of multiple sclerosis. The company was incorporated in 1959 and is headquartered in Buenos Aires, Argentina.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Buenos Aires, Argentina
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.